Tag: EMA
International Perspectives on NTI Generics: Regulatory Approaches Compared
NTI generics require stricter regulation than regular generics due to their narrow safety margin. This article compares how the FDA, EMA, Canada, and Japan handle bioequivalence, pricing, and substitution rules - and why global alignment is still a work in progress.